1.	Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma Phase: Phase IV Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: KMUH-IRB-960044, NCT00630084
2.	STI571 ProspectIve RandomIzed Trial: SPIRIT Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 030482, NCT00219739
3.	Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy Phase: Phase III Type: Treatment Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: SHEBA-06-4015-IH-CTIL, NCT00297570
4.	Multi Centre Trial of DSMM for Newly Diagnosed Multiple Myeloma up to 60 Years Phase: Phase III Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: DSMM V, NCT00546988
5.	Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma Phase: Phase II Type: Treatment Status: Active Age: 21 and under Sponsor: Other Protocol IDs: MEL06, NCT00539591
6.	Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CD-2007-01, NCT00610389
7.	A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EC 1942-02, HARECCTR0500039, NCT00563095